Ophthalmology and Artificial Intelligence: Present or Future? A Diabetic Retinopathy Screening Perspective of the Pursuit for Fairness.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

3 citing papers in PubMed.

1. The acceptance of ophthalmic artificial intelligence for eye diseases: a literature review and qualitative analysis.Eye (London, England) · 2025
   Review
2. Comprehensive Review on the Use of Artificial Intelligence in Ophthalmology and Future Research Directions.Diagnostics (Basel, Switzerland) · 2022
   Review
3. Feasibility of screening for diabetic retinopathy using artificial intelligence, Brazil.Bulletin of the World Health Organization · 2022
   Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

4 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as